NLB Resource - Clinical Trials
Myeloma patients should be considered for clinical trials during all phases of treatment. The novel agents available for myeloma have all been developed through the clinical trials process, substantially increasing survival of myeloma patients over a short period of time.
Search the Myeloma Matrix 2.0 to locate clinical trials for myeloma by geographic location and phase of treatment
Comprised of oncology-certified nurses, the Nurse Leadership Board has extensive knowledge of the multiple myeloma treatment and care landscape. These resources were developed by their team.
Last Medical Review: August 1, 2019